Skip to Main Content

Paper Details

Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidatesfor targeted treatment.
Nat Commun
54
2021
MATCH, NCI, PDX, PDX models, PDXs, cancer, human, pan-cancer, patient, patient-derived xenograft (PDX) models, patient-derived xenograft models, tumors, whole-genome
Author NameAffiliation
Song CaoWashington University in St. Louis
Song CaoMcDonnell Genome Institute, Washington University in St. Louis
Song CaoWashington University in St. Louis
Song CaoMcDonnell Genome Institute, Washington University in St. Louis
Robert J MashlWashington University in St. Louis
Robert J MashlMcDonnell Genome Institute, Washington University in St. Louis
Robert J MashlWashington University in St. Louis
Robert J MashlMcDonnell Genome Institute, Washington University in St. Louis
Chia-Kuei MoWashington University in St. Louis
Chia-Kuei MoMcDonnell Genome Institute, Washington University in St. Louis
Michael C WendlMcDonnell Genome Institute, Washington University in St. Louis
Michael C WendlWashington University in St. Louis
Michael C WendlWashington University in St. Louis
Michael C WendlMcDonnell Genome Institute, Washington University in St. Louis
Michael C WendlWashington University in St. Louis
Michael C WendlWashington University in St. Louis
Sherri R DaviesWashington University in St. Louis
Matthew H BaileyHuntsman Cancer Institute, University of Utah
Tina PrimeauWashington University in St. Louis
Jeremy HoogWashington University in St. Louis
Matthew A WyczalkowskiWashington University in St. Louis
Matthew A WyczalkowskiMcDonnell Genome Institute, Washington University in St. Louis
Matthew A WyczalkowskiWashington University in St. Louis
Matthew A WyczalkowskiMcDonnell Genome Institute, Washington University in St. Louis
Reyka G JayasingheWashington University in St. Louis
Reyka G JayasingheMcDonnell Genome Institute, Washington University in St. Louis
Reyka G JayasingheWashington University in St. Louis
Reyka G JayasingheMcDonnell Genome Institute, Washington University in St. Louis
Nadezhda V TerekhanovaWashington University in St. Louis
Nadezhda V TerekhanovaMcDonnell Genome Institute, Washington University in St. Louis
Yize LiWashington University in St. Louis
Yize LiMcDonnell Genome Institute, Washington University in St. Louis
Cynthia X MaWashington University in St. Louis
Cynthia X MaSiteman Cancer Center, Washington University in St. Louis
John F DiPersioWashington University in St. Louis
John F DiPersioSiteman Cancer Center, Washington University in St. Louis
Matthew J EllisBaylor College of Medicine
Michael T LewisBaylor College of Medicine
Michael T LewisBaylor College of Medicine
Michael A DaviesThe University of Texas MD Anderson Cancer Center
Michael A DaviesThe University of Texas MD Anderson Cancer Center
Meenhard HerlynThe Wistar Institute
Alana L WelmHuntsman Cancer Institute, University of Utah
Alana L WelmHuntsman Cancer Institute, University of Utah
Bryan E WelmHuntsman Cancer Institute, University of Utah
Funda Meric-BernstamThe University of Texas MD Anderson Cancer Center
Feng ChenWashington University in St. Louis
Feng ChenWashington University in St. Louis
Shunqiang LiWashington University in St. Louis
Shunqiang LiSiteman Cancer Center, Washington University in St. Louis
  • 1 - 50

Datasets